Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Insight Molecular Diagnostics Inc. (IMDX) vs MBody AI Ltd. (MBAI)

Insight Molecular Diagnostics Inc. and MBody AI Ltd. are both Diagnostics & Research companies. Insight Molecular Diagnostics Inc. is the larger, with a market value of $129.3M against $69.0M — 1.9× the size. MBody AI Ltd. has the higher net margin (0.00% vs −2,955.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Insight Molecular Diagnostics Inc. leads on 7 and MBody AI Ltd. on 5.

Valuation

Metric IMDX MBAI Diagnostics & Research median
P/E n/m n/m 33.95
P/S 86.26 n/m 4.87
P/B n/m 1.02 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales 75.74 n/m 5.66
Earnings yield (38.01%) (457.38%) (1.75%)
Free cash flow yield (21.52%) (338.71%) (0.13%)

Profitability

Metric IMDX MBAI Diagnostics & Research median
Gross margin 48.32% 0.00% 50.89%
Operating margin (3,011.86%) 0.00% (8.57%)
Net margin (2,955.63%) 0.00% (6.37%)
Free cash flow margin (1,856.23%) 0.00% 0.00%
Return on equity 488.68% 0.00% (2.92%)
Return on assets (123.46%) 0.00% (6.71%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMDX MBAI Diagnostics & Research median
Revenue growth (TTM) (60.77%) — 7.69%
EPS growth (last fiscal year) 64.59% 115.35% —
Revenue growth, 5-year CAGR 27.24% — 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMDX MBAI Diagnostics & Research median
Debt to equity (0.04) 0.00 0.11
Current ratio 2.00 0.71 2.02
Net debt to EBITDA (0.67) 0.09 0.78

Dividend

Metric IMDX MBAI Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric IMDX MBAI Diagnostics & Research median
Market cap 129.26m 68.97m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack